Healthcare news and intelligence for Southern Africa

Daily reporting for the pharmaceutical, medical scheme and hospital sectors, published by Health Matters since 1994.

8 October 2026

Cancer in South Africa is rising, with deaths forecast to nearly double by 2050. Learn what ageing, smoking and urbanisation mean for care.

Latest

More news

15 August 2024

Mpox outbreak in African countries highlights the need for a regional response. Strengthening surveillance, control measures, and vaccine access is crucial.

14 August 2024

Business Unity South Africa opposes the upcoming health compact's focus on NHI, arguing that it is unaffordable and unworkable.

14 August 2024

Liberty says the closure of its health unit is due to a ‘lack of scale’ resulting in operating losses.

14 August 2024

Explore how Gauteng fails cancer patients amid political battles over healthcare reform and the National Health Insurance.

14 August 2024

The National Health Insurance (NHI) Act is a reality, sparking hopes for universal healthcare, yet concerns over patient choice and care quality persist.

13 August 2024

ICPA-member pharmacies still await payment for extra Covid-19 vaccine doses, raising concerns about financial risks under National Health Insurance.

13 August 2024

Africa CDC is set to declare a public health emergency as a fast-spreading Mpox outbreak impacts six countries, with over 12,300 cases and 500 deaths reported.

13 August 2024

While health budgets are the responsibility of the Gauteng treasury, high-cost items for cancer care are sometimes procured through national funding.

13 August 2024

Despite many organisations offering practical suggestions on how universal healthcare could work, Motsoaledi and the ANC ignored them.

11 August 2024

Discover the benefits of Discovery, which combines Vitality units to create a unified strategy and leadership for the global business.

9 August 2024

Health Minister Aaron Motsoaledi has announced a roadshow to promote National Health Insurance (NHI), but stakeholders remain doubtful of its effectiveness.

9 August 2024

A Joburg woman has dropped her case against US drug giant, Vertex after the price of Trikafta, a cystic fibrosis medicine, price is cut.

The archive

Browse every Health Matters article by month.

Get Health Matters every day

Subscribe for the daily briefing, every article in full and the complete archive. Corporate plans cover up to 10 people.

SubscribeLog in